Interim commissioning guidance: implementation of the NICE technology appraisal TA1026 and the NICE funding variation for tirzepatide (Mounjaro®) for the management of obesity Document first published: 27 March 2025 Page updated: 2 April 2026 Topic: Commissioning, Prevention Publication type: Guidance This interim commissioning guidance outlines NHS England’s approach to implementing tirzepatide (Mounjaro®) into the weight […]